A statistical-physics approach for codon usage optimisation |
Comput Struct Biotechnol J. |
Luna-Cerralbo D, Blasco-Machín I, Adame-Pérez S,..., Bruscolini P. |
ON-124ON-004ON-039ON-025R1331R2331R3331R5-027
|
BspQIT7 RNA polymeraseRibonuclease Inhibitor, Human PlacentaPyrophosphatase Inorganic (yeast)ATP 100mM solutionGTP 100mM solutionCTP 100mM solutionN1-Me-pUTP, 100mM solution |
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice |
bioRxiv |
Weiss A, Gilbert JW, Flores IVR,..., Khvorova A |
ON-418
|
Cholesterol tetraethylene glycol (TetraEG) (plant source) |
Preventing acute neurotoxicity of CNS therapeutic oligonucleotides with the addition of Ca2+ and Mg2+ in the formulation |
bioRxiv |
Miller R, Paquette J, Barker A,..., Aronin N |
PD1-001PD2-001PD2-002PD3-001PD5-001PR1-001PR2-001PR2-002PR3-001PR5-001
|
DMT-2'-F-dA(Bz)-CE-PhosphoramiditeDMT-2'-F-dG(dmf)-CE-PhosphoramiditeDMT-2'-F-dG(iBu)-CE-PhosphoramiditeDMT-2'-F-dC(Ac)-CE PhosphoramiditeDMT-2'-F-dU-CE PhosphoramiditeDMT-2'-O-Me-A(Bz)-CE PhosphoramiditeDMT-2'-O-Me-G(dmf)-CE PhosphoramiditeDMT-2'-O-Me-G(iBu)-CE PhosphoramiditeDMT-2'-OMe-C(Ac)-CE-PhosphoramiditeDMT-2'-O-Me-U-CE Phosphoramidite |
Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates |
Nucleic Acids Res. |
Yu M, Qin J, Liu X,..., Nair JK |
PR1-002PR2-005PR3-009PR4-001
|
2'-O-4'-C-Locked-A(Bz) phosphoramidite2'-O-4'-C-Locked-G(dmf) Phosphoramidite2'-O-4'-C-Locked-5-Me-C(Bz) Phosphoramidite2'-O-4'-C-Locked-T Phosphoramidite |
Broad-spectrum Delta-BA.2 tandem-fused heterodimer mRNA vaccine delivered by lipopolyplex |
PLoS Pathog. |
Du P, Huang L, Fang Y,..., Gao GF |
ON-040ON-257ON-269
|
High Yield T7 RNA Synthesis KitCapped RNA Synthesis KitCapped RNA Synthesis Kit (with tailing) |
Intravenous administration of IL-12 encoding self-replicating RNA-lipid nanoparticle complex leads to safe and effective antitumor responses |
Sci Rep. |
Wang Z, Chen Y, Wu H,..., Liu Y |
ON-062RN31ON-025ON-039ON-004ON-028ON-073ON-074ON-014R2331
|
10X IVT Reaction BufferNTP 25mM MixPyrophosphatase Inorganic (yeast)Ribonuclease Inhibitor, Human PlacentaT7 RNA polymeraseVaccinia Capping Enzyme10X Capping BufferS-adenosylmethionine (SAM),32mMmRNA Cap-2'-O-MethyltransferaseGTP 100mM solution |
Immunogenicity and effectiveness of an mRNA therapeutic vaccine for HPV-related malignancies |
Life Sci Alliance. |
Wang J, Ma L, Chen Y,..., Cen S |
R5-027
|
N1-Me-pUTP, 100mM solution |
CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia |
J Transl Med. |
Yang N, Zhang C, Zhang Y,..., He Z. |
ON-124ON-124-G
|
BspQIBspQI (10U/ul) |
Self-delivering, chemically modified CRISPR RNAs for AAV co-delivery and genome editing in vivo |
Nucleic Acids Res. |
Zhang H, Kelly K, Lee J,..., Sontheimer EJ |
ON-133
|
GalNAc-Cluster-COONa |
An mRNA vaccine against rabies provides strong and durable protection in mice |
Front Immunol. |
Li M, Fang E, Wang Y,..., Li Y |
ON-040
|
High Yield T7 RNA Synthesis Kit |
Purification of linearized template plasmid DNA decreases double-stranded RNA formation during IVT reaction |
Front Mol Biosci. |
Martínez J, Lampaya V, Larraga A,..., Casabona D |
R5-027
|
N1-Me-pUTP, 100mM solution |
Ligand-based adoptive T cell targeting CA125 in ovarian cancer |
J Transl Med. |
Zhao H, Wu L, Dai J,..., Zhang L |
ON-257ON-269
|
Capped RNA Synthesis KitCapped RNA Synthesis Kit (with tailing) |
Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines against cancer and infectious diseases |
Signal Transduct Target Ther. |
Gu Y, Yang J, He C,..., Shi H |
ON-124ON-124-G
|
BspQIBspQI (10U/ul) |
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy in vivo |
Res Sq. |
Hariharan VN, Caiazzi J, Miller R,..., Yamada K |
PR5-001
|
DMT-2'-O-Me-U-CE Phosphoramidite |
Algorithm for optimized mRNA design improves stability and immunogenicity |
Nature |
Zhang H, Zhang L, Lin A,..., Huang L |
ON-109ON-028ON-179
|
DNase I (RNase-free)Vaccinia Capping EnzymeAlkaline Phosphatase, TAB5 |
RNAi-mediated rheostat for dynamic control of AAV-delivered transgenes |
Nat Commun. |
Subramanian M, McIninch J, Zlatev I,..., Jadhav V |
PR1-002PR2-005PR2-003PR3-009PR5-006PR4-001D1-004D3-003R2-001R5-002
|
2'-O-4'-C-Locked-A(Bz) phosphoramidite2'-O-4'-C-Locked-G(dmf) Phosphoramidite2'-O-4'-C-Locked-G(iBu)-CE Phosphoramidite2'-O-4'-C-Locked-5-Me-C(Bz) Phosphoramidite5'-O-DMTr-2'-O-4'-C-Locked-U Phosphoramidite2'-O-4'-C-Locked-T Phosphoramidite2'-F-dA2'-F-dC2'-OMe-Gr2'-OMe-Ur |
Low Resource Integrated Platform for Production and Analysis of Capped mRNA |
ACS Synth Biol. |
Nwokeoji AO, Chou T, Nwokeoji EA |
ON-028ON-073
|
Vaccinia Capping Enzyme10X Capping Buffer |
An engineered T7 RNA polymerase that produces mRNA free of immunostimulatory byproducts |
Nat Biotechnol. |
Dousis A, Ravichandran K, Hobert EM,..., Rabideau AE |
R1331R2331R3331R5331
|
ATP 100mM solutionGTP 100mM solutionCTP 100mM solutionUTP 100mM solution |
Rational development of a combined mRNA vaccine against COVID-19 and influenza |
NPJ Vaccines |
Ye Q, Wu M, Zhou C,..., Qin CF |
ON-028ON-014
|
Vaccinia Capping EnzymemRNA Cap-2'-O-Methyltransferase |
Structurally constrained phosphonate internucleotide linkage impacts oligonucleotide-enzyme interaction, and modulates siRNA activity and allele specificity |
Nucleic Acids Res. |
Yamada K, Hildebrand S, Davis SM,..., Khvorova A |
R5-003D5-010
|
DMT-2'-OMe-UrDMT-2'-F-dU |
Synergistic Deoxynucleoside and Gene Therapies for Thymidine Kinase 2 Deficiency |
Ann Neurol. |
Lopez-Gomez C, Sanchez-Quintero MJ, Lee EJ,..., Hirano M |
PD3-003PD3-007PD4-002
|
DMT-dC(Bz)-CE-PhosphoramiditeDMT-dC(Ac)-CE-PhosphoramiditeDMT-dT-CE-Phosphoramidite |
Quantification of T4-Like and T7-Like Cyanophages Using the Polony Method Show They Are Significant Members of the Virioplankton in the North Pacific Subtropical Gyre |
Front Microbiol. |
Goldin S, Hulata Y, Baran N, Lindell D |
DN34
|
dNTP 2.5mM Mix |
Bioavailability and cytosolic kinases modulate response to deoxynucleoside therapy in TK2 deficiency |
eBioMedicine |
Lopez-Gomez C, Hewan H, Sierra C,..., Hirano M |
D300D400
|
2'-dC2'-dT |
Deoxycytidine and deoxythymidine treatment for thymidine kinase 2 deficiency |
Ann Neurol. |
Lopez-Gomez C, Levy RJ, Sanchez-Quintero MJ,..., Hirano M |
D3100D4100D300D400
|
dCMP·H2dTMP·H22'-dC2'-dT |
Biosynthesis of 2′-Chloropentostatin and 2′-Amino-2′-Deoxyadenosine Highlights a Single Gene Cluster Responsible for Two Independent Pathways in Actinomadura sp. Strain ATCC 39365 |
Appl Environ Microbiol. |
Gao Y, Xu G, Wu P,..., Chen W |
D6-002
|
2'-NH2-dI |
An unusual UMP C-5 methylase in nucleoside antibiotic polyoxin biosynthesis |
Protein Cell |
Chen W, Li Y, Li J,..., Zhou J |
R5-012D5-008R5-011
|
5-Br-UMP·Na25-Br-dUMP·Na25-Me-UMP, Sodium Salt |
Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency |
EMBO Mol Med. |
Garone C, Garcia-Diaz B, Emmanuele V,..., Hirano M |
D3100D4100
|
dCMP·H2dTMP·H2 |
Mycobacterial MazG Safeguards Genetic Stability via Housecleaning of 5-OH-dCTP |
PLoS Pathog. |
Lyu LD, Tang BK, Fan XY,..., Zhao GP |
R5-046
|
5-OMe-UTP 100mM solution |
Histone H4 Lysine 12 Acetylation Regulates Telomeric Heterochromatin Plasticity in Saccharomyces cerevisiae |
PLoS Genet. |
Zhou BO, Wang SS, Zhang Y,..., Zhou JQ |
D3100D3-005
|
dCMP·H25-Me-dCMP·Na2 |